marketing customer engagement
Published on : Jul 2, 2025
In an industry where "omnichannel" has been the gold standard, PharmaForceIQ is flipping the script. The fast-rising player in life sciences marketing technology is betting big on something bolder—and smarter: optichannel engagement, where the focus shifts from being everywhere to being exactly where it matters.
And so far? That bet’s paying off.
PharmaForceIQ is currently the fastest-growing independent provider of precision customer engagement tech for the life sciences sector. Over the past year, it’s not only grown contract values multifold, but also pulled off rare feats—like expanding a pilot campaign with a major client from a single specialty brand to the entire specialty pharmaceutical portfolio in just seven months.
It helps that their client renewal rate sits at a clean 100%, which is practically unheard of in this corner of martech. But it’s the results-first strategy—data-driven, optimized in real-time—that keeps clients doubling down.
While the term omnichannel has become marketing table stakes, optichannel is the emerging upgrade—a model where campaigns are continuously optimized to use only the most relevant channels for each target, in real time. The goal? Hyper-personalization that trims fat (and budget waste) while boosting campaign precision.
“PharmaForceIQ is transforming how the life sciences industry engages with customers by enabling rapid applications of real-world data,” said Stephen Onikoro, Chief Operating Officer. “Technology now empowers teams to leverage data in new ways, and optichannel maximizes personalization, effectiveness, and cost savings.”
Translation: Stop broadcasting. Start engaging—with actual relevance.
At the helm of this strategic evolution is Hemal Somaiya, Chief Strategy Officer, whose approach to marketing disruption has earned serious recognition. In 2025 alone, Somaiya was named both a Women of Distinction honoree by MM+M and a 'Disrupter' in the PM360 ELITE 100—no small feat in a sector known for its regulatory complexity and glacial change cycles.
“I’m passionate about creating more meaningful value for HCPs and patients, not more noise,” said Somaiya. “PharmaForceIQ empowers commercial leaders to personalize outreach with advanced analytics, machine learning, and AI—not someday, but today.”
The life sciences space is under pressure to show ROI, reduce wasted ad spend, and—most importantly—engage prescribers and patients in ways that actually improve outcomes. Optichannel marketing helps brands move from mass repetition to micro-relevance, using data signals to make every campaign smarter and more human.
While larger legacy players are still wrestling with disconnected stacks and rigid workflows, PharmaForceIQ’s nimble, AI-first model is proving there’s a faster way to future-proof. Real-time optimization isn’t a pipe dream; it’s platform-native.
With a 100% renewal rate, rapid contract growth, and expanding client footprints, PharmaForceIQ seems positioned to challenge—and possibly leapfrog—some entrenched incumbents in the life sciences marketing tech world.
As the industry pivots toward value-based care and greater transparency, tools that actually deliver results (instead of dashboards full of lagging metrics) will define the winners.
PharmaForceIQ’s optichannel pivot might just be the wake-up call marketers didn’t know they needed.
Get in touch with our MarTech Experts.